Inhalation of honey reduces airway inflammation and
histopathological changes in a rabbit model of ovalbumin-induced chronic
asthma
BMC Complement Altern Med, 2014 May 29;14(1):176
BACKGROUND:
Honey is widely used in folk medicine to treat cough, fever,
and inflammation. In this study, the effect of aerosolised honey on airway
tissues in a rabbit model of ovalbumin (OVA)-induced asthma was investigated.
The ability of honey to act either as a rescuing agent in alleviating
asthma-related symptoms or as a preventive agent to preclude the occurrence of
asthma was also assessed.
METHODS:
Forty New Zealand white rabbits were sensitized twice with
mixture of OVA and aluminium hydroxide on days 1 and 14. Honey treatments were
given from day 23 to day 25 at two different doses (25% (v/v) and 50% (v/v) of
honey diluted in sterile phosphate buffer saline. In the aerosolised honey as a
rescue agent group, animals were euthanized on day 28; for the preventive
group, animals were further exposed to aerosolised OVA for 3 days starting from
day 28 and euthanized on day 31. The effects of honey on inflammatory cell
response, airway inflammation, and goblet cell hyperplasia were assessed for
each animal.
RESULTS:
Histopathological analyses revealed that aerosolised honey
resulted in structural changes of the epithelium, mucosa, and submucosal
regions of the airway that caused by the induction with Ova. Treatment with
aerosolised honey has reduced the number of airway inflammatory cells present
in bronchoalveolar lavage fluid and inhibited the goblet cell hyperplasia.
CONCLUSION:
In this study, aerosolised honey was used to effectively
treat and manage asthma in rabbits, and it could prove to be a promising
treatment for asthma in humans. Future studies with a larger sample size and
studies at the gene expression level are needed to better understand the
mechanisms by which aerosolised honey reduces asthma symptoms.
No comments:
Post a Comment